Artinis and NIRx are two leading developers of fNIRS systems. Both companies sell their systems to universities and other institutions across the globe. NIRx is headquartered in Berlin (DE), with a local sales office in Orlando, Florida (US) and Artinis is headquartered in Elst (NL).

An fNIRS (functional near-infrared spectroscopy) system is a non-invasive and portable type of imaging equipment that can measure and map brain activity. fNIRS measures the absorption of near-infrared light by the brain to determine the location and intensity of brain activity. Use cases include studies on neurodegenerative diseases (e.g. Parkinson, Alzheimer), sports science and real-world applications. Artinis and NIRx develop state-of-the-art fNIRS and other related systems with complementary software.

Gilde Healthcare supports NIRx and Artinis in growing its leading market position by driving the adoption of fNIRS in the broader brain imaging market. Additionally, Gilde Healthcare aims to support the companies in further internationalization and growth, both organically and through targeted M&A.